Search Results - "Shulman, N"

Follow-up care of cancer survivors: challenges and solutions by Jacobs, Linda A, Prof, Shulman, Lawrence N, Prof

“…Summary Attention to survivors of adult cancers formally began more than 30 years ago with the founding of the National Coalition for Cancer Survivorship by…”
Get full text

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199 by Adams, Sylvia, Gray, Robert J, Demaria, Sandra, Goldstein, Lori, Perez, Edith A, Shulman, Lawrence N, Martino, Silvana, Wang, Molin, Jones, Vicky E, Saphner, Thomas J, Wolff, Antonio C, Wood, William C, Davidson, Nancy E, Sledge, George W, Sparano, Joseph A, Badve, Sunil S

“…Recent studies suggest that tumor-infiltrating lymphocytes (TILs) are associated with disease-free (DFS) and overall survival (OS) in operable triple-negative…”
Get full text

Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium by Dietz, Jill R., Moran, Meena S., Isakoff, Steven J., Kurtzman, Scott H., Willey, Shawna C., Burstein, Harold J., Bleicher, Richard J., Lyons, Janice A., Sarantou, Terry, Baron, Paul L., Stevens, Randy E., Boolbol, Susan K., Anderson, Benjamin O., Shulman, Lawrence N., Gradishar, William J., Monticciolo, Debra L., Plecha, Donna M., Nelson, Heidi, Yao, Katharine A.

“…The COVID-19 pandemic presents clinicians a unique set of challenges in managing breast cancer (BC) patients. As hospital resources and staff become more…”
Get full text

Importance of Health Information Technology, Electronic Health Records, and Continuously Aggregating Data to Comparative Effectiveness Research and Learning Health Care by Miriovsky, Benjamin J, Shulman, Lawrence N, Abernethy, Amy P

“…Rapidly accumulating clinical information can support cancer care and discovery. Future success depends on information management, access, use, and reuse…”
Get full text

Maternal and neonatal outcomes of pregnancies in women with Addison's disease: a population‐based cohort study on 7.7 million births by Schneiderman, M, Czuzoj‐Shulman, N, Spence, AR, Abenhaim, HA

“…Objective To assess if pregnancies among women with Addison's disease (AD) are at higher risk of adverse maternal and neonatal outcomes. Design…”
Get full text

Delays in Breast Cancer Presentation and Diagnosis at Two Rural Cancer Referral Centers in Rwanda by Pace, Lydia E., Mpunga, Tharcisse, Hategekimana, Vedaste, Dusengimana, Jean‐Marie Vianney, Habineza, Hamissy, Bigirimana, Jean Bosco, Mutumbira, Cadet, Mpanumusingo, Egide, Ngiruwera, Jean Paul, Tapela, Neo, Amoroso, Cheryl, Shulman, Lawrence N., Keating, Nancy L.

“…Background. Breast cancer incidence is increasing in low‐ and middle‐income countries (LMICs). Mortality/incidence ratios in LMICs are higher than in…”
Get full text

Scan-associated distress in lung cancer: Quantifying the impact of “scanxiety” by Bauml, Joshua M., MD, Troxel, Andrea, ScD, Epperson, C. Neill, MD, Cohen, Roger B., MD, Schmitz, Kathryn, PhD, MSCE, Stricker, Carrie, RN, PhD, Shulman, Lawrence N., MD, Bradbury, Angela, MD, Mao, Jun J., MD, MSCE, Langer, Corey J., MD

“…Highlights • Scan-associated distress is a common problem for patients with lung cancer. • Scan-associated distress is associated with worse quality of life. •…”
Get full text

A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101 by MICHAEL BALDWIN, R, OWZAR, Kouros, FRIEDMAN, Paula N, HUDIS, Clifford A, WINER, Eric P, JORGENSON, Eric M, WITTE, John S, SHULMAN, Lawrence N, NAKAMURA, Yusuke, RATAIN, Mark J, KROETZ, Deanna L, ZEMBUTSU, Hitoshi, CHHIBBER, Aparna, KUBO, Michiaki, JIANG, Chen, WATSON, Dorothy, ECLOV, Rachel J, MEFFORD, Joel, MCLEOD, Howard L

“…Sensory peripheral neuropathy is a common and sometimes debilitating toxicity associated with paclitaxel therapy. This study aims to identify genetic risk…”
Get full text

Expansion of cancer care and control in countries of low and middle income: a call to action by Farmer, Paul, Prof, Frenk, Julio, MD, Knaul, Felicia M, Dr, Shulman, Lawrence N, MD, Alleyne, George, MD, Armstrong, Lance, Atun, Rifat, Prof, Blayney, Douglas, MD, Chen, Lincoln, MD, Feachem, Richard, Prof, Gospodarowicz, Mary, MD, Gralow, Julie, MD, Gupta, Sanjay, MD, Langer, Ana, MD, Lob-Levyt, Julian, MD, Neal, Claire, MPH, Mbewu, Anthony, MD, Mired, Dina, HRH, Piot, Peter, Prof, Reddy, K Srinath, MD, Sachs, Jeffrey D, Prof, Sarhan, Mahmoud, MD, Seffrin, John R, PhD

“…Summary Substantial inequalities exist in cancer survival rates across countries. In addition to prevention of new cancers by reduction of risk factors,…”
Get full text

Tumor Boards and the Quality of Cancer Care by KEATING, Nancy L, LANDRUM, Mary Beth, LAMONT, Elizabeth B, BOZEMAN, Samuel R, SHULMAN, Lawrence N, MCNEIL, Barbara J

“…Despite the widespread use of tumor boards, few data on their effects on cancer care exist. We assessed whether the presence of a tumor board, either general…”
Get full text

Global disparities in access to cancer care by dos-Santos-Silva, Isabel, Gupta, Sudeep, Orem, Jackson, Shulman, Lawrence N.

“…Despite the significant advances made in our understanding of cancer and how to treat it over the last hundred years, there are wide global disparities in…”
Get full text

Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features by GOLDSTEIN, Lori J, GRAY, Robert, SLEDGE, George W, PEREZ, Edith A, SHULMAN, Lawrence N, MARTINO, Silvana, SPARANO, Joseph A, BADVE, Sunil, CHILDS, Barrett H, YOSHIZAWA, Carl, ROWLEY, Steve, SHAK, Steven, BAEHNER, Frederick L, RAVDIN, Peter M, DAVIDSON, Nancy E

“…Adjuvant! is a standardized validated decision aid that projects outcomes in operable breast cancer based on classical clinicopathologic features and therapy…”
Get full text

A Systematic Review of Barriers to Breast Cancer Care in Developing Countries Resulting in Delayed Patient Presentation by Meara, John G., Shulman, Lawrence N., Costas, Ainhoa, Sharma, Ketan

“…Background. Within the developing world, many personal, sociocultural, and economic factors cause delayed patient presentation, a prolonged interval from…”
Get full text

Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic by Nimgaonkar, Vivek, Aggarwal, Charu, Berman, Abigail T, Gabriel, Peter, Shulman, Lawrence N, Kucharczuk, John, Roy, Megan, Bauml, Joshua M, Singh, Aditi P, Cohen, Roger B, Langer, Corey J, Marmarelis, Melina E

“…Abstract Background To ensure safe delivery of oncologic care during the COVID-19 pandemic, telemedicine has been rapidly adopted. However, little data exist…”
Get full text

Oncologist phenotypes and associations with response to a machine learning-based intervention to increase advance care planning: Secondary analysis of a randomized clinical trial by Li, Eric, Manz, Christopher, Liu, Manqing, Chen, Jinbo, Chivers, Corey, Braun, Jennifer, Schuchter, Lynn Mara, Kumar, Pallavi, Patel, Mitesh S, Shulman, Lawrence N, Parikh, Ravi B

“…While health systems have implemented multifaceted interventions to improve physician and patient communication in serious illnesses such as cancer, clinicians…”
Get full text

Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced Cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial by Manz, Christopher R, Schriver, Emily, Ferrell, William J, Williamson, Joelle, Wakim, Jonathan, Khan, Neda, Kopinsky, Michael, Balachandran, Mohan, Chen, Jinbo, Patel, Mitesh S, Takvorian, Samuel U, Shulman, Lawrence N, Bekelman, Justin E, Barnett, Ian J, Parikh, Ravi B

“…Patients with advanced cancer undergoing chemotherapy experience significant symptoms and declines in functional status, which are associated with poor…”
Get full text

Development, acceptability and usability of culturally appropriate survivor narrative videos for breast cancer treatment in Botswana: a pilot study by Martei, Yehoda M, Mokokwe, Lebogang, Ngwako, Ngwao, Kebuang, Keaobaka, Setlhako, Dipho I, Gabaatlhole, Goitsemang, Baaitse, Bontswanetse, Segadimo, Tumisang, Shulman, Lawrence N, Barg, Frances, Gaolebale, Babe E

“…ObjectivesNarrative communication has demonstrated effectiveness in promoting positive health behaviours, delivering support and coping with complex…”
Get full text

Pregnancy outcomes in women with osteogenesis imperfecta: a retrospective cohort study by Ruiter-Ligeti, J, Czuzoj-Shulman, N, Spence, A R, Tulandi, T, Abenhaim, H A

“…Objective: Osteogenesis imperfecta (OI) is a rare genetic disorder characterized by defects in type I collagen that can pose serious complications during…”
Get full text

Influence of chronic hepatitis C infection on cytochrome P450 3a4 activity using midazolam as an in vivo probe substrate by Morcos, P. N., Moreira, S. A., Brennan, B. J., Blotner, S., Shulman, N. S., Smith, P. F.

“…Purpose Inflammation-related changes in pharmacokinetics have been described for a number of disease-states including cancer, infection, and autoimmune…”
Get full text

Six Cycles of Doxorubicin and Cyclophosphamide or Paclitaxel Are Not Superior to Four Cycles As Adjuvant Chemotherapy for Breast Cancer in Women With Zero to Three Positive Axillary Nodes: Cancer and Leukemia Group B 40101 by Shulman, Lawrence N, Cirrincione, Constance T, Berry, Donald A, Becker, Heather P, Perez, Edith A, O'Regan, Ruth, Martino, Silvana, Atkins, James N, Mayer, Erica, Schneider, Charles J, Kimmick, Gretchen, Norton, Larry, Muss, Hyman, Winer, Eric P, Hudis, Clifford

“…The ideal duration of adjuvant chemotherapy for patients with lower risk primary breast cancer is not known. Cancer and Leukemia Group B trial 40101 was…”
Get full text